The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Greenberg Robert J. since year 2005.
The trader's CIK number is 1625594.
At the time of this reporting, Greenberg Robert J. is the Director of Pulse Biosciences, Inc. .
(stock ticker symbol PLSE).
See this page for all insider trading activities at Pulse Biosciences, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-05-10||PLSE||Pulse Biosciences, Inc.||Option Ex||25,000||2.67||66,750|
|2017-05-10||PLSE||Pulse Biosciences, Inc.||Sale||25,000||21.45||536,225|
|2016-12-01||EYES||Second Sight Medical Products Inc||Sale||1,950||1.96||3,822|
|2016-06-02||EYES||Second Sight Medical Products Inc||Sale||8,571||4.10||35,141|
|2016-04-18||EYES||Second Sight Medical Products Inc||Option Ex||8,223||5.00||41,115|
|2016-04-18||EYES||Second Sight Medical Products Inc||Sale||8,223||5.27||43,326|
|2015-12-07||EYES||Second Sight Medical Products Inc||Option Ex||17,969||4.75||85,352|
|2015-12-07||EYES||Second Sight Medical Products Inc||Sale||17,969||5.30||95,235|
|2015-06-03||EYES||Second Sight Medical Products Inc||Option Ex||71,847||4.75||341,273|
|2015-06-02||EYES||Second Sight Medical Products Inc||Sale||78,153||13.96||1,091,015|
|2015-06-03||EYES||Second Sight Medical Products Inc||Sale||71,847||14.12||1,014,479|
|2015-06-02||EYES||Second Sight Medical Products Inc||Option Ex||78,153||4.75||371,226|
|2015-03-23||EYES||Second Sight Medical Products Inc||Sale||1,258||13.40||16,857|
|2015-03-20||EYES||Second Sight Medical Products Inc||Sale||98,742||13.28||1,311,293|
|2015-01-01||EYES||Second Sight Medical Products Inc||Option Ex||59,063||4.75||280,549|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenberg Robert J. (Director of Pulse Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.